While I applaud the efforts to lower drug prices via the IRA, other elements in this legislation have the potential to overshadow and negate these cost savings. With this legislation comes new administrative burdens for overtaxed retail pharmacists and pharmacy staffs (see recent walkouts by Pharmacy staff at CVS and Walgreens nationwide) and under resourced independent pharmacies. Additionally, some provisions may harm federal grantee healthcare providers, such as federally qualified health centers, Ryan White HIV/ AIDS centers, and AIDS drug assistance programs.
While I applaud the efforts to lower drug prices via the IRA, other elements in this legislation have the potential to overshadow and negate these cost savings. With this legislation comes new administrative burdens for overtaxed retail pharmacists and pharmacy staffs (see recent walkouts by Pharmacy staff at CVS and Walgreens nationwide) and under resourced independent pharmacies. Additionally, some provisions may harm federal grantee healthcare providers, such as federally qualified health centers, Ryan White HIV/ AIDS centers, and AIDS drug assistance programs.